Sigurgeirsson, B., Schäkel, K., Hong, C., Effendy, I., Placek, W., Rich, P., Keefe, D., Bruin, G., Charef, P., Fu, R., Hampele, I., & Patekar, M. (2022). efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study. Journal of dermatological treatment, 33, 1718–1726. http://access.bl.uk/ark:/81055/vdc_100156456578.0x000031